Choice of Vascular Access in Critically Ill Patients: Is It Time to Consider the Risk of Drug-Induced Phlebitis?

Carolina Gallardo; Francisco Alvarez; Mario Cremata Bruna; Sebastian Alfaro; Nicolás Severino; Eduardo Kattan

doi:10.1111/nicc.70385

March 1, 2026

Choice of Vascular Access in Critically Ill Patients: Is It Time to Consider the Risk of Drug-Induced Phlebitis?

View at Publisher

Ask AI

Bookmark

Share

Key Points

The review aims to provide a framework for making vascular-access decisions that consider the risk of drug-induced phlebitis in critically ill patients.
Review of existing literature on vascular access and phlebitis
Development of a pharmacology-based decision-making framework
Guidance for critical care nurses on vascular access practices
Identification of key factors influencing phlebitis risk
Recommendations for safer vascular access techniques
Emphasis on optimizing patient safety through informed decision-making

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

This review outlines a framework to guide vascular-access choices, reducing phlebitis risk and enhancing patient safety.

Abstract

This review provides critical care nurses with a practical, pharmacology-based framework to guide vascular-access decisions, reduce phlebitis risk and optimise patient safety.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gallardo et al. (2026) studied this question.

synapsesocial.com/papers/698acad77c832249c30ba5fc https://doi.org/10.1111/nicc.70385

View at Publisher

Ask AI

Bookmark

Share

Choice of Vascular Access in Critically Ill Patients: Is It Time to Consider the Risk of Drug-Induced Phlebitis?

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Choice of Vascular Access in Critically Ill Patients: Is It Time to Consider the Risk of Drug-Induced Phlebitis?

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading